dc.contributor.author | Machumi, F | |
dc.contributor.author | Midiwo, JO | |
dc.contributor.author | MR Jacob | |
dc.contributor.author | Khan, SI | |
dc.contributor.author | Tekwani, BL | |
dc.contributor.author | Walker, LA | |
dc.contributor.author | Muhammad, I | |
dc.date.accessioned | 2013-06-21T06:33:37Z | |
dc.date.available | 2013-06-21T06:33:37Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Planta Med 2013; 79 - P87 | en |
dc.identifier.uri | https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1336529 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/37133 | |
dc.description.abstract | Terminalia brownii is an African medicinal plant used to treat parasitic and microbial infections [1]. Chromatographic separations on the stem bark extract aimed at identifying the active components led to isolation of a new oleanane-type triterpenoid, along with seven known oleanane-type triterpenoids and seven ellagic acid derivatives. The new compound was identified using spectroscopic methods as 3β,24-O-ethylidenyl-2α,19α-dihydroxyolean-12-en-28-oic acid (1). The compounds were evaluated for their antiplasmodial, antileishmanial and antimicrobial activities giving the most potent antiplasmodial activity with IC50 values of 2.76 µg/mL for 23-galloylarjunolic acid (2) against P. falciparum W2 strain and the most potent antimicrobial activity with IC50 values of 0.32 µg/mL for diellagic lactone (3) against C. glabrata. | en |
dc.language.iso | en | en |
dc.title | Phytochemical, Antiparasitic and Antimicrobial Investigations of Terminalia brownii | en |
dc.type | Article | en |
local.publisher | Department of Chemistry, University of Nairobi | en |